SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response: 0.5

1. Name and Address of Reporting Person* Brown Dennis M (Last) (First) (Middle) SUITE 720-999 WEST BROADWAY (Street) VANCOUVER A2 V5Z 1K5 (City) (State) (Zip)	2. Date of Event Requiring Statement (Month/Day/Year) 01/25/2013	3. Issuer Name and Ticker or Trading Symbol DelMar Pharmaceuticals, Inc. [ DMPI ]
		4. Relationship of Reporting Person(s) to Issuer (Check all applicable) X Director X 10% Owner X Officer (give title below) Other (specify below) Chief Scientific Officer	5. If Amendment, Date of Original Filed (Month/Day/Year)
			6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	2,903,542(1)	I	See Footnote(1)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Warrants	02/01/2012	02/01/2017	Common Stock	500,000	$0.5(2)	I	See Footnote(3)
Warrants	10/03/2011	01/25/2014	Common Stock	100,000	(4)	D
Warrants	02/27/2012	01/25/2014	Common Stock	240,000	(5)	D
Options	02/01/2012	02/01/2022	Common stock	150,000	$0.5(2)	D

Explanation of Responses:

1. Includes 1,253,542 shares of the Issuer's common stock owned directly by Reporting Person and 1,650,000 shares of the Issuer's common stock held by Valent Technologies LLC, of which Reporting Person is the sole member and owner and holds sole voting and dispositive power over its shares

2. Actual exercise price is CAD$0.50 (Canadian dollar). The price listed in this Form 3 is the American dollar equivalent as of February 11, 2013, at which time CAD$0.50 exchanged into USD$0.50.

3. Owned by Valent Technologies LLC, of which Reporting Person is the sole member and owner and holds sole voting and dispositive power over its shares

4. Through July 25, 2013 the exercise price of such remaining warrants is USD$0.96. Thereafter through the expiration date the exercise price of such remaining warrants shall be USD $1.20.

5. Through July 25, 2013 the exercise price of such remaining warrants is USD$0.96. Thereafter through the expiration date the exercise price of such remaining warrants shall be USD $1.20.

Remarks:

	/s/ Dennis Brown	02/15/2013
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.